NCT01877707已完成不适用
A Home-based, Rapid and Quantitative Test for Bacterial Respiratory Infections in Patients With Cystic Fibrosis, to Reduce Admissions and Hospital Stay Length and to Improve Healthcare Outcomes.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
- 试验地点
- 2
- 主要终点
- Advance warning of an infective exacerbation
研究概览
简要总结
To identify whether home monitoring of multiple physiological parameters and biomarkers in sputum could provide advanced warning of an infective exacerbation or treatment failure before changes in patient-reported symptoms.
详细描述
- To determine if longitudinal profiling of sputum from Cystic Fibrosis patients allow accurate prediction of exacerbations in a study of a larger group and can we confirm the 7+ day early warning system works in this larger group.
- Is one biomarker sufficient to predict exacerbations - what is the accuracy? Are two or more biomarkers required to achieve an accuracy of greater than 95%?
- Can we now accurately determine how many hospital bed days a home testing/wellness monitoring device would save? What is the business case for healthcare providers to adopt our future test for home use? We estimate a 50% saving. Can this be confirmed?
- When used in the clinic, how many hospital days would our test save through faster determination of treatment efficacy? What is the business case for adopting our future test as a point of care test on the ward in Cystic Fibrosis centres? Could this be the new revolutionary tool that we anticipate?
- We forecast a 50% reduction in costs to treat Cystic Fibrosis patients in disease severity bands 2-A to 5. Can we provide evidence for this to support further investment?
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 17 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of Cystic Fibrosis based on genetic testing and/or sweat chloride levels.
- •Chronic infection with Pseudomonas aeruginosa.
- •Patients able to produce daily sputum samples.
- •Current history of at least two pulmonary infective exacerbations in the past 12 months.
- •Able to give written informed consent
排除标准
- •Unable to provide written informed consent
- •Patients unable to produce daily sputum samples
- •Fewer than two infective pulmonary exacerbations in 12 months
结局指标
主要结局
Advance warning of an infective exacerbation
时间窗: one year
To identify whether home monitoring of multiple physiological parameters and biomarkers in sputum could provide advanced warning of an infective exacerbation or treatment failure before changes in patient-reported symptoms. Participants will collect daily sputum samples which will be profiled for psuedomonas aeruginosa.
次要结局
- home monitoring of multiple physiological parameters(one year)
研究者
Judy Ryan
Research & Database Manager
Papworth Hospital NHS Foundation Trust
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
Development of a sputum biomarker panel to diagnose different types of asthmaasthmaEUCTR2011-000924-14-BEKU Leuven LRD
已完成
不适用
Rapid Turnaround, Home-based Saliva Testing for COVID-19Covid19NCT04568122Stanford University1,277
已完成
不适用
Monitoring of Biomarkers by Portable Breath Gas Sensors: an Exploratory StudyGeneral PopulationNCT02685241University of Zurich70
已完成
不适用
The Colorectal Breath Analysis (COBRA) StudyColorectal PolypsColorectal AdenocarcinomaColorectal CancerNCT03699163Imperial College London1,855
终止
不适用
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate CancerProstate CancerNCT03256630Genomic Health®, Inc.128